Skip to main content
Ingredients/Compound/Mannose

Mannose.

Read pending.Mannose is in the library; the clinical read is in the queue.

Research-backed compound with potential health benefits.

500 to 2,000mgDaily amount225,556Studies read

Reviewed March 2026

MACompound
MannoseIngredientMD
Category
Compound

What Mannose is, and what it does.

Does it work
Good evidence for UTI-prone individuals. Works for prevention, not treatment.
How much to take
Start with 500mg to 2,000mg a day, which is the daily maintenance band. Trials have used 4,000mg, a research condition rather than a daily target. Splitting it across the day suits many people.
Time to feel it
Absorbed within an hour or two, and urinary mannose rises the same day. Changes in urinary comfort are read across days of steady use rather than one dose.
The first dose
It's absorbed within an hour or two and urinary mannose rises the same day. There's no sensation attached to that. The change sits in what's in your urine, not in how you feel.
With regular use
Across weeks of daily use, urinary comfort is what the human work has tracked. Nothing builds up in tissue, since most of an absorbed dose leaves in urine largely unchanged.
How well tolerated
Generally considered well tolerated at normal doses.
How it feels
It's a mildly sweet powder that dissolves in water. No lift, no sedation. The change shows up in urinary comfort across days of steady use rather than as a sensation.
The overlooked benefit
Past the urinary angle, mannose is the donor sugar for N-linked glycosylation and for the mannose-6-phosphate tag that routes enzymes into the lysosome.

500 to 2,000mg a day is where Mannose works.

How much to take a dayMedium confidence
500 to 2,000mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
4,000mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 6,000mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑02,000mg4,000mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Kranjcec et al., World J Urol 2014; D-mannose UTI prevention studies

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Read pending.

Mannose is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.

  • urinary tract comfortRandomised trial
  • blocking bacterial FimH adhesion to urinary surfacesIn vitro study
  • supply of the donor sugar for N-linked glycosylationNarrative review
  • urinary excretion of an oral dose largely unchangedRandomised trial
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI225,556 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI225,556 studies readLabs test. IngredientMD verifies.

Questions people ask about Mannose.

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Pairs well with14 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Mannose + Cranberry Extractcomplementary anti-adhesion mechanisms

Mannose occupies the FimH lectin on type 1 fimbriae so bacteria attach to the sugar rather than to the bladder lining, while cranberry proanthocyanidins interfere with P-type fimbrial attachment. The two cover different adhesins, which is why they are formulated together.

Mannose + Galactoseshared intestinal hexose transport

Mannose, glucose and galactose share intestinal hexose carriers including GLUT-mediated uptake. Large co-ingested doses of another hexose lower the fraction of mannose absorbed intact and excreted in urine.

Mannose + Lactobacillus rhamnosus GGcomplementary colonisation resistance

Mannose blocks bacterial attachment directly, while lactobacilli occupy urogenital surfaces and lower local pH. The two act on attachment from opposite sides.

Mannose + Lactobacillus Acidophiluscomplementary colonisation resistance

Acidophilus produces lactic acid and hydrogen peroxide that discourage settlement by other organisms. That works alongside the physical blocking of fimbrial attachment by mannose.

Mannose + Glucosamineshared glycosylation substrate pool

Mannose is converted to GDP-mannose for N-linked glycan assembly, while glucosamine feeds the hexosamine pathway toward UDP-GlcNAc. Both supply the sugar donors that glycoprotein synthesis draws on.

Mannose + GlucoseEstablished shared intestinal transport

Mannose and glucose are both taken up across the intestinal brush border by the same transporter family, with GLUT-mediated uptake shared between them. A large glucose load in the same window therefore competes with mannose for absorption capacity. That is why mannose is usually taken away from a carbohydrate-heavy meal, and it is transport chemistry rather than an interaction between two supplements.

Mannose + FructoseEstablished shared hexose transport

Fructose crosses the intestinal wall largely through GLUT5 and shares onward GLUT2 handling with other hexoses. Where transport capacity overlaps, a large fructose load takes up part of it. The consequence is one of timing rather than of any chemical incompatibility.

Mannose + Saccharomyces boulardiiEstablished lectin-binding chemistry of yeast cell wall mannans

Yeast cell walls are rich in mannan and mannoprotein, presenting mannose residues on their outer surface. Type 1 fimbrial FimH lectins on certain bacteria bind mannose residues wherever they find them, including on yeast mannan. Pairing free mannose with a mannan-bearing yeast supplies the same recognition motif from two sources; the binding chemistry is established, the clinical consequence is not established from a combination trial.

Mannose + GOS (galactooligosaccharides)Established colonic fermentation of unabsorbed sugars

Mannose that is not absorbed in the small intestine reaches the colon, where resident bacteria can ferment it. Galactooligosaccharides are a defined fermentable substrate reaching the same compartment. Stacking two fermentable carbohydrates raises the total gas-producing load, which is the practical thing to watch rather than a benefit to assume.

Mannose + InulinEstablished colonic fermentation of unabsorbed carbohydrate

Inulin ferments rapidly in the proximal colon and unabsorbed mannose arrives in the same region. The combination increases the fermentable substrate available to the microbiota at one time. People sensitive to fermentable carbohydrates feel this as bloating, so total load matters more than which sugars are in the mix.

Mannose + Lactobacillus plantarumEstablished microbial utilisation of mannose

Lactobacilli carry phosphotransferase systems capable of importing mannose and routing it into glycolysis, and several strains also present surface adhesins. Providing free mannose alongside a defined strain supplies a substrate that strain can use. Which strains actually use it varies, so the pairing should be judged strain by strain rather than at the genus level.

Mannose + Vitamin CTraditional co-formulation in urinary-support products

Ascorbate and mannose appear together in urinary support formulas, where the rationale offered is a change in urinary chemistry alongside mannose's own urinary excretion. The pairing is formulation convention with a long history rather than a tested combination. No trial has separated what each contributes.

Mannose + InositolEstablished shared hexose and phosphorylation chemistry

Inositol is a cyclitol handled by its own transporters but sitting alongside the hexose pool, and mannose enters cells and is phosphorylated by hexokinase. Both feed phosphorylated sugar pools used in membrane and glycan chemistry. The connection is metabolic geography rather than a demonstrated interaction.

Mannose + Ascorbic acidEstablished shared transport chemistry between hexoses and dehydroascorbate

Dehydroascorbate, the oxidised form of vitamin C, enters cells through GLUT transporters that also carry hexoses, which is why high sugar concentrations can compete with its uptake in laboratory systems. Mannose is one of those hexoses. The competition is documented at the transporter level and its practical significance at ordinary intakes has not been established.

Who should be cautious

Nothing specific on file for Mannose. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Mannose actually does.

Established

D-mannose is a hexose epimer of glucose, differing only at carbon two, which is why the two share transporters and why hexokinase accepts both.

Established

Once inside a cell, mannose is phosphorylated by hexokinase to mannose-6-phosphate, converted by phosphomannomutase to mannose-1-phosphate and then to GDP-mannose, the donor sugar for N-linked glycosylation.

Established

Mannose-6-phosphate can also be converted by mannose phosphate isomerase to fructose-6-phosphate, which routes it into glycolysis, so mannose is both a glycosylation substrate and a fuel depending on where the cell needs it.

Established

Mannose-6-phosphate tags on lysosomal enzymes are the recognition signal that directs those enzymes to the lysosome, one of the clearest examples of a sugar residue acting as an address label in cell biology.

More than one route, 6 steps on record

Where Mannose comes from.

D-mannose usually starts as a plant fibre that already contains mannose locked into long chains, often from hardwood or from seeds. That chain is broken apart, the mannose is separated out from the other sugars that come with it, and it is crystallised into a white powder. Some producers make it by fermentation or by converting fructose instead; the finished molecule is the same either way.

The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.

Starts as
Mannan-rich plant material, commonly birch or beech wood, ivory nut or konjac

Commercial D-mannose is generally made from plant polysaccharides that are rich in mannose residues rather than isolated from a food directly.

Converted by
Acid or enzymatic hydrolysis of the mannan

The polysaccharide chain is cleaved to release free mannose along with other monosaccharides present in the source polymer.

Purified by
Separation from co-released sugars

Chromatographic separation, ion exchange and decolourisation remove glucose, galactose and other co-released sugars along with hydrolysis by-products.

Converted by
Crystallisation

The purified mannose is concentrated and crystallised out of solution, which is the step that sets its purity grade.

Standardised to
Assay of identity and purity

The crystalline material is checked for identity and purity, including confirmation that it is the D enantiomer, and residual sugars are held to a specification.

Ends up as
Crystalline powder, or capsule fill

The finished sugar is milled to a target particle size and either packed as a powder or blended with flow agents for encapsulation.

Getting Mannose from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

CranberriesApplesPeaches

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

D-mannose powderThe free sugar in crystalline form, readily soluble in water and dosed by weight.Fits Dosing by the gram in water, and any format where the amount needs to be adjusted rather than fixed.Trade-off It is sweet and hygroscopic, it clumps in humid conditions, and dosing by scoop is less precise than a fixed unit.
Encapsulated D-mannoseThe same free monosaccharide blended with flow agents and filled to a fixed weight per capsule.Fits Fixed daily dosing and travel, where consistency per unit is the point.Trade-off Reaching a multi-gram intake takes several capsules, and the excipient share reduces active weight per unit.
Blended urinary-support formulaMannose combined with plant extracts, most commonly cranberry proanthocyanidins, in a single powder or capsule.Fits Products aimed at a single use occasion where the formulator wants more than one mechanism represented.Trade-off The mannose dose per serving is usually much lower than in a single-ingredient product, and a blend cannot show which component is doing what.
The non-natural enantiomerThe mirror image of D-mannose, which mammalian enzymes and transporters do not handle in the same way.Fits Chemistry and analytical reference use.Trade-off It is not the form used in supplements or the form the metabolic pathways described here act on, so the D and L designation on a label is not cosmetic.Formulation aid
What the strongest studies found

The essence, in one line each.

  1. In a randomised controlled design in adult cats, D-mannose supplementation was associated with changes in immune measures and in gut microbiota composition; the findings are in cats and are compositional and marker-level.Animal study. Wang J et al., 2025 (Research in Veterinary Science). PMID 41166862
  2. Dietary mannose supplementation in people with an inherited enzyme deficiency affecting sugar processing did not produce a detectable change in the glycosylation measures tracked; a failure to detect a difference is not evidence that none exists.Open-label trial. Taday R et al., 2020 (Orphanet Journal of Rare Diseases). PMID 32962735
  3. Further reporting on mannose supplementation in the same inherited enzyme deficiency setting did not identify a benefit on the biochemical measures followed; the result is a null on those specific markers.Open-label trial. Taday R et al., 2021 (Orphanet Journal of Rare Diseases). PMID 34380532
  4. A single case describes management and outcomes across pregnancy in a woman with an inherited deficiency of the enzyme that converts mannose-6-phosphate, a setting where mannose is used clinically under specialist supervision; a case report describes one person and establishes nothing about a population.Case report. Loh JHM et al., 2026 (Molecular Genetics and Metabolism Reports). PMID 42376639
  5. D-mannose supplementation of culture medium was used as a method to expand stem-like memory T cells in vitro, which is a laboratory technique and not evidence of an effect from oral intake.In vitro study. Qiu Y et al., 2026 (Methods in Cell Biology). PMID 42177043
  6. Mannose exposure altered migration and invasion properties of the cultured bone cell lines examined; this is cell-culture work on isolated cell lines with no bearing on what an oral dose does in a person.In vitro study. Morita A et al., 2026 (Biology). PMID 41594862
  7. A computational network analysis of shared molecular links between excess body weight and reduced bone density was paired with mannose supplementation experiments; the computational part generates hypotheses rather than measuring an effect.In vitro study. James R et al., 2025 (Scientific Reports). PMID 40789846
  8. Osteocyte Pink1 and Prkn signalling was reported to modulate mannose-6-phosphate metabolism in the model used, which names mannose metabolism as a downstream node rather than testing mannose supplementation.Animal study. Mei J et al., 2026 (Journal of Orthopaedic Translation). PMID 42182074

These are the studies our verdict leans on, chosen from the 8 we read for Mannose. The full linked list is below.

Primary evidence

The studies, linked.

10 sources behind our Mannose verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.

  1. ClinicalTrials.gov
  2. ClinicalTrials.gov
  3. ClinicalTrials.gov
  4. ClinicalTrials.gov
  5. ClinicalTrials.gov
  6. ClinicalTrials.gov
  7. ClinicalTrials.gov
  8. ClinicalTrials.gov
  9. Clinical trialStudy of ORL-1M (D-mannose) in Patients With CDG-Ib
    PHASE1 · 5 participants · Unknown
    ClinicalTrials.gov
  10. ClinicalTrials.gov

Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.

Side effects reported to the FDA

Problems people have reported.

Read this carefully. These are 1,975 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Mannose is, not how risky it is. A report is not proof Mannose caused anything. It is a signal of what to watch for, nothing more.

Urinary Tract Infection
96
Fatigue
76
Diarrhoea
57
Headache
57
Arthralgia
54
Nausea
53

Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.

On the shelf

What Mannose comes in.

Products in our catalog that carry it, read the same way every product here is read.